Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
Publié dans: | Nature Cancer 4(2023)1, S. 96-107 |
---|---|
Auteurs principaux: | , , , |
Format: | Article |
Langue: | English |
Publié: |
2023
|
Sujets: | |
Accès en ligne: | https://doi.org/10.1038/s43018-022-00503-w |
Documents similaires: | In:
Nature Cancer |
Description: | Exemplar/Standort: Open Access |
---|---|
DOI: | 10.1038/s43018-022-00503-w |
Cote: | Open Access |